CALC CalciMedica, Inc.

P/E --
Forward P/E --
Price/Sales --
Beta 1.106
Div Yield --
Market Cap --

Company Analysis

Latest News

🟢 CalciMedica is trading 5.1% up today on after-hours rebound, following Alafi Capital's recent 17.1% stake disclosure

CalciMedica is trading at $0.86 (5.1% up) in after-hours, staging a recovery after a sharp drop during the regular trading session. • The stock is rebounding...

🟢 CalciMedica is trading 5.1% up today on a speculative after-hours rebound

CalciMedica is trading at $0.86 (5.1%) up in after-hours trading as shares stage a speculative rebound following a volatile regular session. • The stock...

🟢 CalciMedica is trading 13.2% up today on speculative after-hours activity

CalciMedica is trading at $0.93 (+13.19%) in after-hours trading following a sharp rebound from its regular session close of $0.82, despite no clear...

🔴 CalciMedica is trading 10.4% down

CalciMedica is trading at $0.83, down 10.4% from a comparison close of $0.93 during regular trading. This is a price-action follow-up, so a separate catalyst...

🔴 CalciMedica is trading 5.99% down today on Nasdaq delisting risk and biotech sector weakness

CalciMedica is trading at $0.87 (5.99% down) as investors react to ongoing Nasdaq delisting risk and a weak biotech tape. • The company recently disclosed...

🔴 CalciMedica is trading 6.3% down today after board-appointment rally and profit-taking

CalciMedica is trading at $0.89 (6.3% down) as the stock faces profit-taking pressure following a short-lived rally driven by a board expansion. • The stock...

🔴 CalciMedica is trading 5.3% down today as after-hours profit-taking follows board expansion rally

CalciMedica is trading at $0.90 (5.3% down) in after-hours sessions as investors lock in gains following a board-related rally during regular trading. • The...

🟢 CalciMedica is trading 5.6% up today after announcing board expansion and new director appointment

CalciMedica is trading 5.6% up at $0.95 after announcing changes to its board of directors. • The company expanded its board from seven to eight members and...

🟢 CalciMedica is trading 6.2% up today after announcing board changes

• CalciMedica is trading at $0.96 (up 6.2%) in pre-market action following news of a shift in top management. • The company announced on July 8, 2026, an...

🔴 CALC extends move to 5.8% down

CALC is trading at $0.90, down 5.8% versus the comparison close of $0.96 during regular trading. This is a price-movement alert; no separate company-specific...

🔴 CALC is trading 5.7% down today as trial discontinuation fallout continues

CALC is trading 5.7% down at $0.90 in pre-market, extending recent weakness following a major clinical trial setback. • The company recently announced it...

CalciMedica Appoints Dr. Evgeny Zaytsev to Board, Announces Director Retirement

CalciMedica Appoints Dr. Evgeny Zaytsev to Board, Announces Director Retirement

CalciMedica announced changes to its Board of Directors, appointing Evgeny Zaytsev, M.D., Ph.D., as a new director and announcing the upcoming retirement of...

🔴 CALC is trading 7.3% down today as traders take profits after activist stake rally

CALC is trading 7.3% down at $0.92 as investors take profits following a sharp multi-day rally triggered by Bering Partners II disclosing a 6.9% activist-style...

CalciMedica Surges on Activist-Style Stake, but Can a Penny Stock With No Revenue Sustain the Momentum?

CalciMedica Surges on Activist-Style Stake, but Can a Penny Stock With No Revenue Sustain the Momentum?

Shares of CalciMedica shifted sharply higher Monday, trading at $1.07 — up 8.8% — as the market continued to digest a July 3 regulatory filing revealing that...

🟢 CALC is trading 8.8% up today following a 6.9% stake disclosure by Bering Partners II

CALC is trading at $1.07 (8.8% up) following a recent Schedule 13D filing disclosing a new investor stake amid ongoing post-rally volatility. • Bering...

🔴 CALC is trading 5.7% down today after a sharp post-rally pullback

CALC is trading at $0.91 (-5.74%) in pre-market following a sharp post-rally pullback, despite broader market strength. • A July 3 13D filing revealed Bering...

CalciMedica Gains 6.9% Holder Via June Private Placement

CalciMedica Gains 6.9% Holder Via June Private Placement

A Schedule 13D filing on July 3, 2026, disclosed that Bering Partners II, L.P. has taken a 6.9% stake in CalciMedica. This position was primarily established...

🔴 CALC makes sharp 10.0% drop

CALC is trading at $0.94, down 10.0% versus the comparison close of $1.04 during regular trading. This is a price-movement alert; no separate company-specific...

🟢 CALC Surges 8.7% as Favorable FDA News, Financing, and Insider Buying Fuel Multi-Day Rally

CALC is trading 8.7% up at $1.12 today, extending its sharp multi-day rally. The sustained speculative momentum is now bolstered by several recent...

🔴 CALC is trading 5.1% down today as profit-taking continues after recent rally

CALC is trading at $0.98 (5.1% down) in pre-market, easing back as the stock continues a cooling-off phase following a sharp multi-session run-up from $0.60 to...